Common Contracts
3 similar Securities Agreement contracts by Adamis Pharmaceuticals Corp, MGT Capital Investments, Inc., T2 Biosystems, Inc.
COMMON STOCK PURCHASE WARRANTSecurities Agreement • August 16th, 2022 • T2 Biosystems, Inc. • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lincoln Park Capital Fund, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 15, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 15, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from T2 Biosystems, Inc., a Delaware corporation (the “Company”), up to [ ● ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of the Company’s Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANTSecurities Agreement • August 11th, 2022 • MGT Capital Investments, Inc. • Services-computer processing & data preparation
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Capital Ten Management, LLC, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the third year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from MGT Capital Investments, Inc., a Delaware corporation (the “Company”), up to a number of shares of Common Stock equal to 7,600,0000 (without taking into account the Beneficial Ownership Limitation) (subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant issued pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) entered into as of t
COMMON STOCK PURCHASE WARRANT ADAMIS PHARMACEUTICALS CORPORATIONSecurities Agreement • July 6th, 2022 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Lincoln Park Capital Fund, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 3, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 5, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), up to 750,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of the Company’s Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
